{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:54:30Z","timestamp":1791172470469,"version":"4.1.0"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1001807","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T16:12:34Z","timestamp":1427213554000},"page":"e1001807","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":135,"title":["Broad Blockade Antibody Responses in Human Volunteers after Immunization with a Multivalent Norovirus VLP Candidate Vaccine: Immunological Analyses from a Phase I Clinical Trial"],"prefix":"10.1371","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct01168401","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Lisa C.","family":"Lindesmith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin T.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clancy W.","family":"Mullan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Debbink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesica","family":"Swanstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Baehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Mendelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Bargatze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph S.","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"key":"ref1","year":"2013"},{"key":"ref2","first-page":"1","article-title":"Updated norovirus outbreak management and disease prevention guidelines","volume":"60","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ajic.2012.08.002","article-title":"Clinical characteristics of norovirus-associated deaths: a systematic literature review","volume":"41","author":"TK Trivedi","year":"2013","journal-title":"Am J Infect Control"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMra1207742","article-title":"Norovirus gastroenteritis in immunocompromised patients","volume":"367","author":"K Bok","year":"2012","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.2012.14023","article-title":"Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009\u20132010","volume":"308","author":"TK Trivedi","year":"2012","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tim.2004.04.005","article-title":"Norovirus disease: changing epidemiology and host susceptibility factors","volume":"12","author":"AM Hutson","year":"2004","journal-title":"Trends Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.qco.0000244053.69253.3d","article-title":"Noroviruses everywhere: has something changed?","volume":"19","author":"MK Estes","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1086\/315573","article-title":"Molecular epidemiology of human enteric caliciviruses in The Netherlands","volume":"181","author":"M Koopmans","year":"2000","journal-title":"J Infect Dis"},{"key":"ref9","first-page":"842","article-title":"Norovirus activity\u2014United States, 2006\u20132007","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wekly Rep"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00705-006-0739-6","article-title":"Genetic analysis of noroviruses associated with fatalities in healthcare facilities","volume":"151","author":"M Okada","year":"2006","journal-title":"Arch Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3201\/eid1410.080188","article-title":"Deaths from norovirus among the elderly, England and Wales","volume":"14","author":"JP Harris","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1086\/653939","article-title":"Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution","volume":"51","author":"R Schorn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3201\/eid1810.120833","article-title":"Epidemiology of foodborne norovirus outbreaks, United States, 2001\u20132008","volume":"18","author":"AJ Hall","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/pubmed\/fdm080","article-title":"Data quality of 5 years of central norovirus outbreak reporting in the European Network for food-borne viruses","volume":"30","author":"A Kroneman","year":"2008","journal-title":"J Public Health (Oxf)"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.virol.2005.11.015","article-title":"Norovirus classification and proposed strain nomenclature","volume":"346","author":"DP Zheng","year":"2006","journal-title":"Virology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/JCM.31.8.2185-2191.1993","article-title":"Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations","volume":"31","author":"KY Green","year":"1993","journal-title":"J Clin Microbiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.286.5438.287","article-title":"X-ray crystallographic structure of the Norwalk virus capsid","volume":"286","author":"BV Prasad","year":"1999","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm860","article-title":"Human susceptibility and resistance to Norwalk virus infection","volume":"9","author":"L Lindesmith","year":"2003","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e0050031","DOI":"10.1371\/journal.pmed.0050031","article-title":"Mechanisms of GII.4 norovirus persistence in human populations","volume":"5","author":"LC Lindesmith","year":"2008","journal-title":"PLoS Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1128\/JVI.03106-12","article-title":"Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes","volume":"87","author":"LC Lindesmith","year":"2013","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.1014577107","article-title":"Chimpanzees as an animal model for human norovirus infection and vaccine development","volume":"108","author":"K Bok","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"A Reeck","year":"2010","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk Virus illness","volume":"365","author":"RL Atmar","year":"2011","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1128\/JVI.00674-07","article-title":"Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006","volume":"81","author":"JJ Siebenga","year":"2007","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e1002705","DOI":"10.1371\/journal.ppat.1002705","article-title":"Immunogenetic mechanisms driving norovirus GII.4 antigenic variation","volume":"8","author":"LC Lindesmith","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/JVI.01364-10","article-title":"Norovirus GII.4 strain antigenic variation","volume":"85","author":"LC Lindesmith","year":"2011","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1128\/JVI.06189-11","article-title":"Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity","volume":"86","author":"K Debbink","year":"2012","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/JVI.02518-08","article-title":"Herd immunity to GII.4 noroviruses is supported by outbreak patient sera","volume":"83","author":"JL Cannon","year":"2009","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/infdis\/jit370","article-title":"Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity","volume":"208","author":"K Debbink","year":"2013","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-065X.2008.00680.x","article-title":"Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations","volume":"225","author":"EF Donaldson","year":"2008","journal-title":"Immunol Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.06200-11","article-title":"Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002","volume":"86","author":"LC Lindesmith","year":"2012","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1128\/JVI.01192-14","article-title":"Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope","volume":"88","author":"LC Lindesmith","year":"2014","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/JVI.03464-12","article-title":"Recombination within the pandemic norovirus GII.4 lineage","volume":"87","author":"JS Eden","year":"2013","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e1000831","DOI":"10.1371\/journal.ppat.1000831","article-title":"Rapid evolution of pandemic noroviruses of the GII.4 lineage","volume":"6","author":"RA Bull","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e1000884","DOI":"10.1371\/journal.ppat.1000884","article-title":"Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants","volume":"6","author":"JJ Siebenga","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1586\/erv.12.145","article-title":"Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis","volume":"12","author":"C Richardson","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/infdis\/jiu337","article-title":"A novel intramuscular bivalent norovirus virus-like particle vaccine candidate-reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults","volume":"210","author":"JJ Treanor","year":"2014","journal-title":"J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrmicro2296","article-title":"Viral shape-shifting: norovirus evasion of the human immune system","volume":"8","author":"EF Donaldson","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3201\/eid1601.090633","article-title":"Norovirus gastroenteritis outbreak with a secretor-independent susceptibility pattern, Sweden","volume":"16","author":"J Nordgren","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/infdis\/jis514","article-title":"Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans","volume":"206","author":"R Frenck","year":"2012","journal-title":"J Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1128\/JVI.79.5.2900-2909.2005","article-title":"Cellular and humoral immunity following Snow Mountain virus challenge","volume":"79","author":"L Lindesmith","year":"2005","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, et al. (2014) Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis. E-pub ahead of print. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1093\/infdis\/jiu497\" xlink:type=\"simple\">10.1093\/infdis\/jiu497<\/ext-link><\/comment>","DOI":"10.1093\/infdis\/jiu497"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1128\/JVI.02793-13","article-title":"Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects","volume":"88","author":"J Swanstrom","year":"2014","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1016\/j.vaccine.2006.03.080","article-title":"Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains","volume":"24","author":"AD LoBue","year":"2006","journal-title":"Vaccine"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.1128\/JVI.00203-14","article-title":"Within-host evolution results in antigenically distinct GII.4 noroviruses","volume":"88","author":"K Debbink","year":"2014","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e1000949","DOI":"10.1371\/journal.pcbi.1000949","article-title":"A computational framework for influenza antigenic cartography","volume":"6","author":"Z Cai","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1073\/pnas.1301810110","article-title":"Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation","volume":"110","author":"F Wang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.meegid.2012.01.020","article-title":"Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients","volume":"12","author":"D Hoffmann","year":"2012","journal-title":"Infect Genet Evol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/bioinformatics\/bts105","article-title":"AntigenMap 3D: an online antigenic cartography resource","volume":"28","author":"JL Barnett","year":"2012","journal-title":"Bioinformatics"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e1002921","DOI":"10.1371\/journal.ppat.1002921","article-title":"Norovirus immunity and the great escape","volume":"8","author":"K Debbink","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/JVI.02179-09","article-title":"Heterotypic humoral and cellular immune responses following Norwalk virus infection","volume":"84","author":"LC Lindesmith","year":"2010","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.1218256109","article-title":"Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody","volume":"110","author":"AG Schmidt","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.1118979109","article-title":"Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells","volume":"109","author":"GM Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jpeds.2011.09.055","article-title":"Immunogenicity and reactogenicity of a monovalent inactivated 2009 influenza A vaccine in adolescents: with special reference to pre-existing antibody","volume":"160","author":"M Kobayashi","year":"2012","journal-title":"J Pediatr"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4161\/hv.23241","article-title":"Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector","volume":"9","author":"MC Knuchel","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)62003-1","article-title":"Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"375","author":"XF Liang","year":"2010","journal-title":"Lancet"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1056\/NEJMoa0908535","article-title":"A novel influenza A (H1N1) vaccine in various age groups","volume":"361","author":"FC Zhu","year":"2009","journal-title":"N Engl J Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"J Wrammert","year":"2008","journal-title":"Nature"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ibd.20280","article-title":"Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids","volume":"14","author":"JR Mora","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.4049\/jimmunol.166.3.1894","article-title":"Protective intestinal anti-rotavirus B cell immunity is dependent on alpha 4 beta 7 integrin expression but does not require IgA antibody production","volume":"166","author":"NA Kuklin","year":"2001","journal-title":"J Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"DJ Smith","year":"2004","journal-title":"Science"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/JCM.00630-09","article-title":"Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008","volume":"47","author":"SW Huang","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1128\/JVI.00785-14","article-title":"Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses","volume":"88","author":"K Debbink","year":"2014","journal-title":"J Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI41902","article-title":"Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine","volume":"120","author":"D Corti","year":"2010","journal-title":"J Clin Invest"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"e1002802","DOI":"10.1371\/journal.ppat.1002802","article-title":"Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China","volume":"8","author":"J Lessler","year":"2012","journal-title":"PLoS Pathog"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1001807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T04:10:35Z","timestamp":1598847035000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1001807"}},"subtitle":[],"editor":[{"given":"Benjamin","family":"Lopman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,24]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1001807","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,24]]}}}